The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services. — CFSMEATLAS
The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services.
Wildwing, Tamar, Holt, Nicole · Therapeutic advances in chronic disease · 2021 · DOI
Quick Summary
This study reviewed 45 existing research papers about neurological symptoms people experience with COVID-19. Researchers found that some COVID-19 patients develop long-lasting symptoms like fatigue and muscle pain that look very similar to ME/CFS and other neurological conditions. The authors suggest that doctors may need better training to recognize and treat these ongoing symptoms, and that healthcare services may need more resources to help patients.
Why It Matters
This work is significant for ME/CFS because it formally documents clinical and symptomatic parallels between Long COVID and ME/CFS, potentially validating patient experiences and creating opportunities for improved clinical recognition. The study suggests that increased awareness of post-viral neurological syndromes due to COVID-19 may shift healthcare professionals' understanding of conditions like ME/CFS, potentially improving diagnosis and care pathways for both populations.
Observed Findings
COVID-19 produces two distinct types of neurological symptoms: acute severe complications (GBS, encephalitis) and persistent milder symptoms (fatigue, myalgia).
Persistent neurological symptoms in COVID-19 patients show clinical similarities to ME/CFS and functional neurological disorder.
Long COVID symptoms appear to represent an emerging longer-term syndrome in some COVID-19 survivors.
Systematic reviews published early in the pandemic (April–October 2020) were readily available across multiple databases.
Inferred Conclusions
The overlap between Long COVID and established neurological conditions like ME/CFS warrants unified clinical and research approaches.
Healthcare systems may need expanded neurological services and trained personnel to manage increased demand from Long COVID patients.
COVID-19 may shift healthcare professionals' perceptions and validation of other post-viral neurological conditions such as ME/CFS.
Future research should examine whether increased COVID-19 awareness changes clinical recognition and management of similar conditions.
Remaining Questions
What are the biological mechanisms linking acute COVID-19 infection to persistent neurological symptoms, and are these mechanisms shared with ME/CFS?
What This Study Does Not Prove
This study does not establish causation or mechanistic pathways underlying Long COVID symptoms, nor does it prove that Long COVID and ME/CFS are identical conditions. As a secondary analysis of systematic reviews conducted early in the pandemic, it cannot confirm prevalence rates, natural history, or treatment efficacy for persistent symptoms. The work does not provide evidence about which patients will develop long-term neurological complications.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →